Year: 2011
Type: article
Abstract: The goal of this study was to assess clinical efficacy and safety of Lavomax and to provide pathogenetic grounds for its use in the complex therapy of patients suffering from genital herpes. The study subjects were 64 patients suffering from genital herpes. Their diagnosis was verified on the basis of ELISA and PCR results. Immunoassays revealed various disorders of immune homeostasis and natural resistance. These results confirm that there are pathogenetic grounds to use Lavomax in the complex therapy of genital herpes. Complex treatment with the use of Lavomax normalizes immune homeostasis and quickly reduces clinical manifestations of herpes significantly reducing the frequency and duration of recurrences of the disease.
DOI: 10.25208/vdv1059
Language: English
Subfield: Infectious Diseases
Field: Medicine
Domain: Health Sciences
Open Access status: diamond
OpenAlex ID: W4211001248
